Onconova Therapeutics
ONTX
$0.72
Share price
0.00%
Change (1 day)
-59.09%
Change (1 year)
Categories
Revenue for Onconova Therapeutics (ONTX)
Revenue in 2022 (TTM): $0.22 M
According to Onconova Therapeutics's latest financial reports the company's current revenue (TTM) is $0.22 M. In 2021 the company made a revenue of $0.22 M a decrease over the years 2020 revenue that were of $0.23 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Onconova Therapeutics from 2012 to 2022
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2022 (TTM) | $0.22 M | |
| 2021 | $0.22 M | -2.16% |
| 2020 | $0.23 M | -89.42% |
| 2019 | $2.18 M | 77.77% |
| 2018 | $1.22 M | 56.04% |
| 2017 | $0.78 M | -85.81% |
| 2016 | $5.54 M | -51.59% |
| 2015 | $11.45 M | 1332% |
| 2014 | $0.8 M | -83.17% |
| 2013 | $4.75 M | -89.71% |
| 2012 | $46.19 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Baxter BAX | $15.11 B | 6,687,068.14% | 🇺🇸 USA |
 Spectrum Pharmaceuticals
SPPI | N/A | N/A | 🇺🇸 USA |
 CTI BioPharma
CTIC | $32.86 M | 14,442.04% | 🇺🇸 USA |
 Cleveland BioLabs
CBLI | $0.63 M | 179.58% | 🇺🇸 USA |
 Array Technologies ARRY | $1.45 B | 642,847.35% | 🇺🇸 USA |